| |
|
|
| Louvre, October 2006 - Press Release |
Labochim celebrated its 40th Anniversary
On 3rd October 2006, Labochim celebrated its 40th Anniversary, with all its clients, suppliers, friends, partners and senior staff.
|
| Milan, June 2006 - Breaking news |
INFA Group executed an investment agreement
On 21st June 2006 INFA Group executed an investment agreement with one of the major and most qualified Italian Private Equity Funds – Investitori Associati – who became the major shareholder of the group.
|
| March, 2005 |
Health & Nutrition News
Alpha Lipoic Acid is known to be one of the most potent and versatile antioxidants, as it helps deactivate an unusually wide array of cell-damaging free radicals in many bodily systems.
|
| Milan, 2005 - breaking news |
Acamprosate - a safe and effective drug to maintain abstinence in alcohol dependent patients.
Labochim is pleased to announce that thanks to its intensive R&D activity is now able to offer its clients a new product: Acamprosate
|
| Milan, 2005 - breaking news |
Pregabalin - the successor of Gabapentin
Further to the introduction of the Italian Bolar Roche, Labochim, one of the leaders in the production of Gabapentin, gave a boost to its R&D activity, introducing several new projects in its pipe-line.
|
|
|
